Literature DB >> 29168934

Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients.

Omar Abdel-Rahman1.   

Abstract

BACKGROUND: The current study tried to evaluate the factors affecting 10- to 20- years' survival among long term survivors (>5 years) of colorectal cancer (CRC).
METHODS: Surveillance, Epidemiology and End Results (SEER) database (1988-2008) was queried through SEER*Stat program.Univariate probability of overall and cancer-specific survival was determined and the difference between groups was examined. Multivariate analysis for factors affecting overall and cancer-specific survival was also conducted.
RESULTS: Among node positive patients (Dukes C), 34% of the deaths beyond 5 years can be attributed to CRC; while among M1 patients, 63% of the deaths beyond 5 years can be attributed to CRC. The following factors were predictors of better overall survival in multivariate analysis: younger age, white race (versus black race), female gender, Right colon location (versus rectal location), earlier stage and surgery (P <0.0001 for all parameters). Similarly, the following factors were predictors of better cancer-specific survival in multivariate analysis: younger age, white race (versus black race), female gender, Right colon location (versus left colon and rectal locations), earlier stage and surgery (P <0.0001 for all parameters).
CONCLUSION: Among node positive long-term CRC survivors, more than one third of all deaths can be attributed to CRC.

Entities:  

Keywords:  Colon cancer; cure; five years; rectal cancer; survival

Mesh:

Year:  2017        PMID: 29168934     DOI: 10.1080/14737140.2018.1409625

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  4 in total

1.  Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.

Authors:  Omar Abdel-Rahman; Hatim Karachiwala
Journal:  Int J Colorectal Dis       Date:  2019-09-06       Impact factor: 2.571

Review 2.  Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases.

Authors:  Omar Abdel-Rahman; Winson Y Cheung
Journal:  Gastroenterol Res Pract       Date:  2018-06-21       Impact factor: 2.260

3.  Characterisation of long-term cancer survivors and application of statistical cure models: a protocol for an observational follow-up study in patients with colorectal cancer.

Authors:  Sonia Pértega-Díaz; Vanesa Balboa-Barreiro; Rocío Seijo-Bestilleiro; Cristina González-Martín; Remedios Pardeiro-Pértega; Loreto Yáñez-González-Dopeso; Teresa García-Rodríguez; Teresa Seoane-Pillado
Journal:  BMC Public Health       Date:  2020-11-17       Impact factor: 3.295

4.  Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study.

Authors:  Yanmei Gu; Haixiao Deng; Daijun Wang; Yumin Li
Journal:  Front Surg       Date:  2021-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.